Role of HIV-2 envelope in Lv2-mediated restriction

被引:28
作者
Reuter, S [1 ]
Kaumanns, P [1 ]
Buschhorn, SB [1 ]
Dittmar, MT [1 ]
机构
[1] Heidelberg Univ, Dept Virol, D-69120 Heidelberg, Germany
关键词
retroviral restriction; HIV-2; Lv2; viral entry;
D O I
10.1016/j.virol.2004.11.025
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have characterized envelope protein pseudotyped HIV-2 particles derived from two HIV-2 isolates termed prCBL23 and CBL23 in order to define the role of the envelope protein for the Lv2-mediated restriction to infection. Previously, it has been described that the primary isolate pi-CBL23 is restricted to infection of several human cell types, whereas the T cell line adapted isolate CBL23 is not restricted in these cell types. Molecular cloning of the two isolates revealed that the env and the gag gene are responsible for the observed phenotype and that this restriction is mediated by Lv2, which is distinct from Ref1/Lv1 (Schmitz, C., Marchant, D., Neil, S.J., Aubin, K., Reuter, S., Dittmar, M.T., McKnight, A., Kizhatil, K., Albritton, L.M., 2004. Lv2, a novel postentry restriction, is mediated by both capsid and envelope. J. Virol. 78 (4), 2006-2016). We generated pseudotyped viruses consisting of HIV-2 (ROD-ADeltaenv-GFP, ROD-ADeltaenv-RFP, or ROD-ADeltaenv-REN) and the prCBL23 or CBL23 envelope proteins as well as chimeric proteins between these envelopes. We demonstrate that a single amino acid exchange at position 74 in the Surface unit of CBL23-Env confers restriction to infection. This single point mutation causes tighter CD4 binding, resulting in a less efficient fusion into the cytosol of the restricted cell line. Prevention of endosome formation and prevention of endosome acidification enhance infectivity of the restricted particles for GHOST/X4 cells indicating a degradative lysosornal pathway as a cause for the reduced cytosolic entry. The described restriction to infection of the priniary isolate prCBL23 is therefore largely caused by an entry defect. A reiriaining restriction to infection (19-fold) is preserved when endosornal acidification is prevented. This restriction to infection is also dependent on the presence of the point inutation at position 74 (G74E). (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:347 / 358
页数:12
相关论文
共 55 条
  • [2] The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages
    Alfano, M
    Pushkarsky, T
    Poli, G
    Bukrinsky, M
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (18) : 8767 - 8770
  • [3] The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains
    Alfano, M
    Schmidtmayerova, H
    Amella, CA
    Pushkarsky, T
    Bukrinsky, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (05) : 597 - 605
  • [4] CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes
    Arthos, J
    Rubbert, A
    Rabin, RL
    Cicala, C
    Machado, E
    Wildt, K
    Hanbach, M
    Steenbeke, TD
    Swofford, R
    Farber, JM
    Fauci, AS
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (14) : 6418 - 6424
  • [5] INTERNALIZATION OF THE HUMAN IMMUNODEFICIENCY VIRUS DOES NOT REQUIRE THE CYTOPLASMIC DOMAIN OF CD4
    BEDINGER, P
    MORIARTY, A
    VONBORSTEL, RC
    DONOVAN, NJ
    STEIMER, KS
    LITTMAN, DR
    [J]. NATURE, 1988, 334 (6178) : 162 - 165
  • [6] Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
    Berger, EA
    Murphy, PM
    Farber, JM
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 : 657 - 700
  • [7] Positional cloning of the mouse retrovirus restriction gene Fv1
    Best, S
    LeTissier, P
    Towers, G
    Stoye, JP
    [J]. NATURE, 1996, 382 (6594) : 826 - 829
  • [8] A SINGLE AMINO-ACID SUBSTITUTION IN THE V1 LOOP OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 ALTERS CELLULAR TROPISM
    BOYD, MT
    SIMPSON, GR
    CANN, AJ
    JOHNSON, MA
    WEISS, RA
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (06) : 3649 - 3652
  • [9] Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton
    Bukrinskaya, A
    Brichacek, B
    Mann, A
    Stevenson, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) : 2113 - 2125
  • [10] A monomeric red fluorescent protein
    Campbell, RE
    Tour, O
    Palmer, AE
    Steinbach, PA
    Baird, GS
    Zacharias, DA
    Tsien, RY
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) : 7877 - 7882